Abstract:
Objective To compare the clinical efficiency and safety between radiofrequency ablation (RFA) and stereotactic body radiotherapy(SBRT) on primary small hepatocellular carcinoma patients with tumor diameter ≤5 cm.
Methods We retrospectively analyzed the clinical data of 86 patients with hepatocellular carcinoma in He'nan Province Tumor Hospital from June 2013 to March 2015, 49 cases in RFA group and 37 cases in SBRT group. The short-term clinical efficiency and adverse effects were compared. The 2-year overall survival(OS) and local control(LC) rate were followed up.
Results There was no significant difference in the baseline characteristics between two groups. Short-term efficiency and the local control rate were 81.9% and 95.9% in RFA group, while 83.8% and 91.9% in SBRT group, with no significant difference. No severe complications occurred in any patients after treatment. The 1-and 2-year overall survival rates were 95.9% and 85.7% in RFA group, while 91.9% and 83.8% in SBRT group, with no significant difference.
Conclusion RFA has comparable short-and long-term effects as SBRT on single hepatocellular carcinoma with tumor diameter ≤5 cm, and SBRT may serve as an alternative option of RFA on hepatocellular carcinoma patients who were unavailable for surgical resection.